IL17A and neoplasm: In addition, TNFSF11 (RANKL)-mediated tumor antigen presentation by the DCs to cytotoxic CD8+ T cells is also dependent on IL-17A.23 Furthermore, Karabulut et al24 found no association between IL-17 levels and the overall survival of CRC patients.